MediXall Group, Inc.
MDXL
$0.0039
$0.000411.43%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -55.29% | 24.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -55.29% | 24.97% | |||
| Cost of Revenue | -18.05% | -45.54% | |||
| Gross Profit | -25.02% | 67.08% | |||
| SG&A Expenses | 23.70% | -69.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.03% | -60.48% | |||
| Operating Income | -24.14% | 68.74% | |||
| Income Before Tax | 0.14% | 66.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.14% | 66.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.14% | 66.55% | |||
| EBIT | -24.14% | 68.74% | |||
| EBITDA | -24.30% | 67.96% | |||
| EPS Basic | 2.38% | 64.10% | |||
| Normalized Basic EPS | 4.35% | 67.14% | |||
| EPS Diluted | 2.38% | 64.10% | |||
| Normalized Diluted EPS | 4.35% | 67.14% | |||
| Average Basic Shares Outstanding | 3.57% | 2.70% | |||
| Average Diluted Shares Outstanding | 3.57% | 2.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||